Effects of Costovertebral Joint Mobilization on Respiratory Function in Asthmatic Patients

Asthmatic Clinical Trial

Official title:

Effects of Costovertebral Joint Mobilization on Respiratory Function in Asthmatic Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06133985
• Other study ID #: REC -01680 Bushra Ali Syed
• Status: Completed
• Phase: N/A
• Start date: October 1, 2023
• Est. completion date: February 1, 2024

Study information

• Verified date: March 2024
• Source: Riphah International University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this randomized controlled trial is to determine the effectiveness of costovertebral joint mobilization on lung function in asthmatics. By targeting the thoracic region, costovertebral mobilization can play a valuable role in enhancing respiratory function and improving the overall well-being of individuals with respiratory conditions.

Description:

Costovertebral joint mobilization can help to improve this by increasing the mobility of the ribs and thoracic spine, which can help to expand the chest and improve lung function. Additionally, costovertebral joint mobilization can help to reduce muscle tension in the chest and upper back, which can also contribute to improved respiratory function. This is because tense or tight muscles can restrict the movement of the rib cage, limiting the ability of the lungs to expand and contract. Mobilization are performed in three positions, sitting, supine lying and side lying with arm abducted of the side to be mobilized. The improvement by regular physical training of breathing technique and chest wall mechanics may be explained by mobilization of the costovertebral articulations.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: February 1, 2024
• Est. primary completion date: February 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• Force Expiratory Volume 1/Force Vital Capacity ratio less than 0.7
• Mild asthma (Force Expiratory Volume 1 over 70% predicted)
• Chest tightness (inspiratory muscle tightness)
• Altered Dyspnea index.

Exclusion Criteria:

• presence of any underlying lung condition other than asthma.
• significant cardiovascular or musculoskeletal disease that may compromise the participant's capacity to participate in physical activity;
• active cancer.
• uncontrolled hypertension or diabetes.

Related Conditions & MeSH terms

• Asthma
• Asthmatic

Intervention

Other:
• Costovertebral mobilizations + Conventional PT
Costovertebral mobilizations along conventional treatment patient would receive costovertebral mobilization in side lying position for 10th to 6th ribs, in sitting position for 10th to 2nd rib and in supine position for 1 rib. Frequency: 5 times/week for 3 weeks. Intensity: moderate intensity (pain free) Time: 10 mins Type: costovertebral joint mobilization to improve respiratory function and chest tightness. Conventional treatment diaphragmatic breathing exercises pursed-lip expiration exercises. Patient will receive diaphragmatic breathing and pursed lip breathing exercise in sitting position Frequency: 5 times/week for 3 weeks Intensity: moderate intensity (pain free) Time: 20 mins Type: breathing exercises to improve respiratory function and chest tightness.
• Conventional treatment
diaphragmatic breathing exercises pursed-lip expiration exercises. Patient will receive diaphragmatic breathing and pursed lip breathing exercise in sitting position Frequency: 5 times/week for 3 weeks Intensity: moderate intensity (pain free) Time: 20 mins Type: breathing exercises to improve respiratory function and chest tightness.

Locations

Country	Name	City	State
Pakistan	Rahim Hospital	Rawalpindi	Punjab

Sponsors (1)

Lead Sponsor	Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of respiratory function FEV1 using spirometer.	Spirometry is one of the Pulmonary Function Test; they are useful investigations in the management of patients with respiratory disease or respiratory weakness secondary to neurological impairment. Spirometry will measure FEV1	3 weeks
Primary	Assessment of respiratory function FVC using spirometer.	Spirometry is one of the Pulmonary Function Test; they are useful investigations in the management of patients with respiratory disease or respiratory weakness secondary to neurological impairment. Spirometry will measure FVC	3 weeks
Primary	Tape for chest expansion	Chest expansion is measured using a measuring tape at 2 different levels of the rib cage. The 2 measurements of chest diameter are taken at the end of deep inspiratory and expiratory maneuvers. Upper and lower chest expansion are obtained by subtracting the inspiratory diameter from the expiratory diameter, according to the designated anatomical markers. The assessment is performed 1 measurement of upper chest expansion and then 1 measurement of the lower chest expansion consecutively, holding the measuring tape at both ends with thumb and index finger around the patient body.	3 weeks
Primary	Dyspnea index	It is used to describe their sense of breathlessness and breathing problem, and the effects of their breathing on their lives.	3 weeks